Advances in Omics Technologies in GBM

Advances in Omics Technologies in GBM

Glioblastoma multiforme (GBM) is one of the most lethal human cancers and poses a great challenge in the therapeutic interventions of GBM patients worldwide. Despite prominent recent advances in oncology, on an average GBM patients survive 12–15 months with conventional standard of care treatment. T...

Full description

Bibliographic Details
Main Authors: Uday B Maachani, Uma Shankavaram, Kevin Camphausen, Anita Tandle
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Biomedical Research Journal
Subjects:
glioblastoma
omics
genomics
transcriptomics
epigenomics
proteomics
metabolomics
Online Access:http://www.brjnmims.org/article.asp?issn=2349-3666;year=2015;volume=2;issue=1;spage=6;epage=20;aulast=Maachani;type=0

Internet

http://www.brjnmims.org/article.asp?issn=2349-3666;year=2015;volume=2;issue=1;spage=6;epage=20;aulast=Maachani;type=0

Similar Items